These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25885792)

  • 1. Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients.
    Leyking S; Budich K; van Bentum K; Thijssen S; Abdul-Khaliq H; Fliser D; Sester M; Sester U
    J Transl Med; 2015 Feb; 13():51. PubMed ID: 25885792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
    Bardet V; Junior AP; Coste J; Lecoq-Lafon C; Chouzenoux S; Bernard D; Soubrane O; Lacombe C; Calmus Y; Conti F
    Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients.
    Albring A; Wendt L; Harz N; Engler H; Wilde B; Kribben A; Lindemann M; Schedlowski M; Witzke O
    Clin Transplant; 2015 Apr; 29(4):294-300. PubMed ID: 25557538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis.
    Marx S; Adam C; Mihm J; Weyrich M; Sester U; Sester M
    Front Immunol; 2020; 11():916. PubMed ID: 32499781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant.
    Kahvecioglu S; Ersoy A; Gullulu M; Dirican M
    Exp Clin Transplant; 2014 Aug; 12(4):334-42. PubMed ID: 24447269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
    Seyhun Y; Ciftci HS; Kekik C; Karadeniz MS; Tefik T; Nane I; Turkmen A; Oguz FS; Aydin F
    Int J Immunogenet; 2015 Jun; 42(3):147-60. PubMed ID: 25817300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell receptor-stimulated calcineurin activity is inhibited in isolated T cells from transplant patients.
    Tumlin JA; Roberts BR; Kokko KE; El Minshawy O; Gooch JL
    J Pharmacol Exp Ther; 2009 Aug; 330(2):602-7. PubMed ID: 19420299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation.
    Parasrampuria DA; Lantz MV; Birnbaum JL; Vincenti FG; Benet LZ
    J Clin Pharmacol; 2002 Mar; 42(3):304-11. PubMed ID: 11865967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents.
    Brito-Costa A; Pereira-da-Silva L; Papoila AL; Alves M; Mateus É; Nolasco F; Barroso E
    Transplantation; 2016 Aug; 100(8):1714-22. PubMed ID: 27136260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell numbers and antigen-specific T-cell function follow different circadian rhythms.
    Kirsch S; Thijssen S; Alarcon Salvador S; Heine GH; van Bentum K; Fliser D; Sester M; Sester U
    J Clin Immunol; 2012 Dec; 32(6):1381-9. PubMed ID: 22797814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
    Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
    Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood.
    Sellar KJ; van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J
    Anal Biochem; 2006 Nov; 358(1):104-10. PubMed ID: 16979577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
    Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
    Ann Transplant; 2014 Jan; 19():32-40. PubMed ID: 24457606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.